# Miguel C. Riella

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/miguel-c-riella/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,849 |
| Field | Dialysis and Renal Disease Management |
| h-index | 47 |
| i10-index | 110 |
| Last Known Institution | Renal Association |
| OpenAlex ID | https://openalex.org/A5048134915 |
| ORCID iD | 0000-0003-4181-613X |
| Works | 287 |

## Researcher papers

- [IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly](https://scholariq.org/papers/il-10-il-6-and-tnf-central-factors-in-the-altered-cytokine-network-of-uremia-the/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/dialysis-initiation-modality-choice-access-and-prescription-conclusions-from-a/)
- [Adult Peritoneal Dialysis-Related Peritonitis Treatment Recommendations: 2000 Update](https://scholariq.org/papers/adult-peritoneal-dialysis-related-peritonitis-treatment-recommendations-2000/)
- [Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/blood-pressure-and-volume-management-in-dialysis-conclusions-from-a-kidney/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Reviews and Original Articles](https://scholariq.org/papers/reviews-and-original-articles/)
- [Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update.](https://scholariq.org/papers/peritoneal-dialysis-related-peritonitis-treatment-recommendations-1996-update/)
- [Recurrence of FSGS after Kidney Transplantation in Adults](https://scholariq.org/papers/recurrence-of-fsgs-after-kidney-transplantation-in-adults/)
- [Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial](https://scholariq.org/papers/efficacy-and-safety-of-aldosterone-synthase-inhibition-with-and-without/)
- [APOL1 risk variants and kidney disease: what we know so far](https://scholariq.org/papers/apol1-risk-variants-and-kidney-disease-what-we-know-so-far/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)

## Researcher university

- [Renal Association](https://scholariq.org/institutions/renal-association/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.